3771 - 3780 of 5832 Results
Title
Year
- Comparative study of PROMISⓇ self-efficacy for managing chronic conditions across chronic neurologic disorders2019OPENTitle: Comparative study of PROMISⓇ self-efficacy for managing chronic conditions across chronic neurologic disordersJournal Name: Quality of Life ResearchPublisher: Springer Science and Business Media LLCVol: 28Issue #: 7Start Page: 1893End Page: 1901Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s11136-019-02164-2Best OA location URL: https://europepmc.org/articles/pmc7071345?pdf=renderCitation Count: 19
- A specific amino acid motif ofHLA-DRB1mediates risk and interacts with smoking history in Parkinson’s disease2019OPENTitle: A specific amino acid motif ofHLA-DRB1mediates risk and interacts with smoking history in Parkinson’s diseaseJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 116Issue #: 15Start Page: 7419End Page: 7424Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.1821778116Best OA location URL: https://www.pnas.org/content/pnas/116/15/7419.full.pdfCitation Count: 68
-
OPENTitle: The Parkinson's disease e‐diary: Developing a clinical and research tool for the digital ageJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 5Start Page: 676End Page: 681Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27673Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114172Citation Count: 53
-
OPENTitle: Discovery of Volatile Biomarkers of Parkinson’s Disease from SebumJournal Name: ACS Central SciencePublisher: American Chemical Society (ACS)Vol: 5Issue #: 4Start Page: 599End Page: 606Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1021/acscentsci.8b00879Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acscentsci.8b00879Citation Count: 132
-
OPENTitle: Cognitive Performance in Parkinson’s Disease in the Brain Health RegistryJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 68Issue #: 3Start Page: 1029End Page: 1038Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jad-181009Best OA location URL: https://europepmc.org/articles/pmc6497062?pdf=renderCitation Count: 10
- Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicity2019OPENTitle: Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicityJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 137Issue #: 6Start Page: 939End Page: 960Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-019-01993-2Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-019-01993-2.pdfCitation Count: 75
-
OPENTitle: Amygdala sign, a FDG-PET signature of dementia with Lewy BodiesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 64Issue #:Start Page: 300End Page: 303Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.03.005Best OA location URL: https://europepmc.org/articles/pmc6739145?pdf=renderCitation Count: 10
- The Combination of DAT-SPECT, Structural and Diffusion MRI Predicts Clinical Progression in Parkinson’s Disease2019OPENTitle: The Combination of DAT-SPECT, Structural and Diffusion MRI Predicts Clinical Progression in Parkinson’s DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2019.00057Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2019.00057/pdfCitation Count: 21
- DNA methylation changes associated with Parkinson’s disease progression: outcomes from the first longitudinal genome-wide methylation analysis in blood2019OPENTitle: DNA methylation changes associated with Parkinson’s disease progression: outcomes from the first longitudinal genome-wide methylation analysis in bloodJournal Name: EpigeneticsPublisher: Informa UK LimitedVol: 14Issue #: 4Start Page: 365End Page: 382Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/15592294.2019.1588682Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/15592294.2019.1588682?needAccess=trueCitation Count: 72
- The Parkinson’s disease-linked Leucine-rich repeat kinase 2 (LRRK2) is required for insulin-stimulated translocation of GLUT42019OPENTitle: The Parkinson’s disease-linked Leucine-rich repeat kinase 2 (LRRK2) is required for insulin-stimulated translocation of GLUT4Journal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-019-40808-yBest OA location URL: https://www.nature.com/articles/s41598-019-40808-y.pdfCitation Count: 25